BACKGROUND: Innate immunity mechanisms have been shown to play a paramount role in organ transplantation. Our aim was to investigate the hypothesis that activation of the interferon system may affect clinically relevant outcomes, such as acute rejection and/or early fibrosis progression, after liver transplantation. METHODS: We studied 71 consecutive recipients (57 males; 25 with hepatitis C) who underwent two per protocol graft biopsies: the first, within 60 days after the transplant operation (median 24) and the second, after 1 year. The mRNA expression for five interferon-stimulated genes (Mx1, OAS2, PKR, IRF7A, IFI16) was measured on the first biopsy specimens. The main outcome measures were acute rejection during the first post-transplant year and fibrosis progression at the second biopsy. RESULTS: On multivariate analysis, the independent predictors of gene expression were hepatitis C (Mx1, OAS2, PKR and IFI16), donor age (IFI16) and recipient gender (IRF7A) (P < .05 for all). During the first post-transplant year, 19/71 patients (27%) had acute cellular rejection. At multivariate analysis, acute cellular rejection was independently predicted by high IRF7A mRNA expression. At the end of follow-up, 25 patients had some degree of fibrosis (F2 or higher in seven cases). On multivariate analysis, hepatitis C etiology, recipient age, and OAS2 overexpression were independent predictors of early fibrosis progression. CONCLUSIONS: In the early postoperative period of liver transplantation, interferon-stimulated gene activation is dependent on hepatitis C recurrence (the main factor responsible for early fibrosis progression) and donor age, and is related to the risk of acute cellular rejection.
BACKGROUND: Innate immunity mechanisms have been shown to play a paramount role in organ transplantation. Our aim was to investigate the hypothesis that activation of the interferon system may affect clinically relevant outcomes, such as acute rejection and/or early fibrosis progression, after liver transplantation. METHODS: We studied 71 consecutive recipients (57 males; 25 with hepatitis C) who underwent two per protocol graft biopsies: the first, within 60 days after the transplant operation (median 24) and the second, after 1 year. The mRNA expression for five interferon-stimulated genes (Mx1, OAS2, PKR, IRF7A, IFI16) was measured on the first biopsy specimens. The main outcome measures were acute rejection during the first post-transplant year and fibrosis progression at the second biopsy. RESULTS: On multivariate analysis, the independent predictors of gene expression were hepatitis C (Mx1, OAS2, PKR and IFI16), donor age (IFI16) and recipient gender (IRF7A) (P < .05 for all). During the first post-transplant year, 19/71 patients (27%) had acute cellular rejection. At multivariate analysis, acute cellular rejection was independently predicted by high IRF7A mRNA expression. At the end of follow-up, 25 patients had some degree of fibrosis (F2 or higher in seven cases). On multivariate analysis, hepatitis C etiology, recipient age, and OAS2 overexpression were independent predictors of early fibrosis progression. CONCLUSIONS: In the early postoperative period of liver transplantation, interferon-stimulated gene activation is dependent on hepatitis C recurrence (the main factor responsible for early fibrosis progression) and donor age, and is related to the risk of acute cellular rejection.
Authors: Wendy E Walker; Isam W Nasr; Geoffrey Camirand; Bethany M Tesar; Carmen J Booth; Daniel R Goldstein Journal: J Immunol Date: 2006-10-15 Impact factor: 5.422
Authors: M J de Veer; M Holko; M Frevel; E Walker; S Der; J M Paranjape; R H Silverman; B R Williams Journal: J Leukoc Biol Date: 2001-06 Impact factor: 4.962
Authors: Stephen C Rayhill; You Min Wu; Daniel A Katz; Michael D Voigt; Douglas R Labrecque; Patricia A Kirby; Frank A Mitros; Roberto S Kalil; Rachel A Miller; Alan H Stolpen; Warren N Schmidt Journal: Transplantation Date: 2007-08-15 Impact factor: 4.939
Authors: Carmen E Gómez; Andrée Marie Vandermeeren; María Angel García; Elena Domingo-Gil; Mariano Esteban Journal: Virol J Date: 2005-09-12 Impact factor: 4.099
Authors: Pritha Sen; Adrian R Wilkie; Fei Ji; Yiming Yang; Ian J Taylor; Miguel Velazquez-Palafox; Emilia A H Vanni; Jean M Pesola; Rosio Fernandez; Han Chen; Liza M Morsett; Erik R Abels; Mary Piper; Rebekah J Lane; Suzanne E Hickman; Terry K Means; Eric S Rosenberg; Ruslan I Sadreyev; Bo Li; Donald M Coen; Jay A Fishman; Joseph El Khoury Journal: Sci Adv Date: 2020-04-22 Impact factor: 14.957